BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2016
View Archived Issues
Clinical safety and pharmacodynamics of VLX-103 in cirrhotic patients with early-stage HCC
Read More
Promising clinical data for TS-23 supports future development in thrombotic vascular diseases
Read More
FDA grants orphan drug designation to Genexine's GX-H9
Read More
Imara doses first volunteer in IMR-687 phase I trial
Read More
ALD-1910 induces photophobia in WT CT1 mice
Read More
Sorrento's TNK Therapeutics signs binding term sheet to acquire Virttu Biologics
Read More
EMA grants PRIME to SAGE-547 for postpartum depression
Read More
Genexine signs agreement with Merck & Co.
Read More
Cuvitru now available in U.S. for patients with primary immunodeficiency
Read More
LLS commits USD 40.3 million to fund new research into hematologic cancers
Read More
AstraZeneca announces completion of MEDI-2070 outlicensing agreement with Allergan
Read More
GTx to advance enobosarm phase II trial to final stage
Read More
Grunenthal acquires Thar Pharmaceutical
Read More
Tianjin Institute of Pharmaceutical Research patents URAT1 inhibitors
Read More
FDA grants fast track designation to crenolanib for GIST
Read More
Concert Pharmaceuticals discloses OTX-015 analogues
Read More
Daewoong Pharmaceutical describes ATPase inhibitors and/or 5-HT2A and/or M1 and/or M2 antagonists
Read More
Agilis Biotherapeutics treats first patient in phase IIb study of AGIL-AADC
Read More
Novartis reports promising topline results from STRIVE trial of AMG-334 in episodic migraine
Read More
Japanese researchers develop antimalarial agents
Read More
Chinese scientists present FXR agonists
Read More
Gilead reports topline results from phase III trials of momelotinib in myelofibrosis
Read More
Antidepressant effects of SUVN-1507035 in animal models of psychosis
Read More
CTC biomarker identifies CRPC patients likely to respond to PARP inhibitor treatment
Read More
Sofosbuvir, ledipasvir and ribavirin give high cure rates in drug users with hepatitis C
Read More
DSMB recommends continuation of phase III study of PXT-003 for CMT1A
Read More
Pfizer initiates phase I trial of PF-06747143 in AML
Read More
CD40L-encoding adenovirus enhances dendritic cell therapy for cancer
Read More
EMA grants positive opinion for teriparatide biosimilar
Read More